A new generation of reversible male contraceptives is advancing through clinical trials to expand family planning options.

Add Yahoo as a preferred source to see more of our stories on Google. Contraline, a biotech company, has received regulatory approval to move onto Phase 2 of human clinical trials for a male ...

Delivery of therapeutic stem cells to treat bone tissue damage is a promising strategy that faces many hurdles to clinical translation. Among them is the design of a delivery vehicle which promotes ...

The team suggests that the lacosamide functions as a dual-purpose treatment that simultaneously alleviated joint pain and ...